Revolutionary therapy slows tumor growth in advanced breast cancer, research reports

ScienceDaily (2010-07-06) -- A novel therapy designed to attack tumors in patients with a genetic mutation in either BRCA1 or BRCA2, slowed tumor growth in 85 percent of advanced breast cancer patients treated in a small study, researchers report.